https://www.selleckchem.com/pr....oducts/crenolanib-cp
05) in patients with and patients without iliopsoas hematoma. Mortality, however, did not differ significantly between the 2 groups. Our findings emphasize that recognizing factors associated with iliopsoas hematoma and detecting them early are crucial during venovenous ECMO in order to treat patients with iliopsoas hematoma appropriately. Our findings emphasize that recognizing factors associated with iliopsoas hematoma and detecting them early are crucial during venovenous ECMO in order to treat patients with iliopsoas he
Like
Comment
Share
